Education
About Us
Working with TipRanks
Follow Us
Onconetix Inc (ONCO)
:ONCO
ONCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.82 - $1,191.64
Previous CloseN/A
Volume794.62K
Average Volume (3M)455.19K
Market Cap
$2.09M
Enterprise Value$25.36B
Total Cash (Recent Filing)$341.50K
Total Debt (Recent Filing)$10.12M
Price to Earnings (P/E)―
Beta2.18
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-88.84
Shares Outstanding521,863
10 Day Avg. Volume334,150
30 Day Avg. Volume455,190
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)24.12
Price to Sales (P/S)0.00
P/FCF Ratio-62.00
Enterprise Value/Market Cap12.15K
Enterprise Value/Revenue6.11K
Enterprise Value/Gross Profit-32.89K
Enterprise Value/Ebitda-139.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Onconetix News
PremiumCompany Announcements
Onconetix Secures Nasdaq Listing with Panel Decision
PremiumCompany Announcements
Onconetix Issues Promissory Note to Keystone CapitalPremiumCompany Announcements
Onconetix Stockholders Approve Reverse Stock Split ProposalPremiumCompany Announcements
Onconetix Faces Nasdaq Delisting Notice Amid Compliance Issues
Options Prices
Currently, No data available
---
Ownership Overview
2.94% Insiders
0.15% Mutual Funds
0.13% Other Institutional Investors
96.78% Public Companies and Individual Investors
ONCO FAQ
What was Onconetix Inc’s price range in the past 12 months?
Onconetix Inc lowest stock price was $3.82 and its highest was $1191.64 in the past 12 months.
What is Onconetix Inc’s market cap?
Onconetix Inc’s market cap is $2.09M.
When is Onconetix Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Onconetix Inc’s earnings last quarter?
Currently, no data Available
Is Onconetix Inc overvalued?
According to Wall Street analysts Onconetix Inc’s price is currently Overvalued.
Does Onconetix Inc pay dividends?
Onconetix Inc does not currently pay dividends.
What is Onconetix Inc’s EPS estimate?
Onconetix Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Onconetix Inc have?
Onconetix Inc has 521,863 shares outstanding.
What happened to Onconetix Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Onconetix Inc?
Currently, no hedge funds are holding shares in ONCO
Onconetix Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.4%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.23%
12-Months-Change
Fundamentals
Return on Equity
-237.69%
Trailing 12-Months
Asset Growth
-74.98%
Trailing 12-Months
Company Description
Onconetix Inc
Onconetix (ONCO) is a biotechnology company specializing in the development and commercialization of innovative cancer diagnostics and therapeutics. The company operates in the healthcare and life sciences sectors, focusing on leveraging advanced technologies to improve cancer detection, treatment, and patient outcomes. Onconetix's core products include a range of diagnostic assays and personalized treatment solutions designed to target specific cancer biomarkers, thereby enabling more effective and tailored treatment regimens.
Technical Analysis
BioMarin Pharmaceutical
―
Exelixis
―
Gilead Sciences
―
Incyte
―
Vertex Pharmaceuticals
―